Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 9 results.
User Information
Export Records
  1. 1.   Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus (HSV) Seronegative Recipients of the HSV529 Vaccine
  2. Wang, Kening; Dropulic, Lesia; Bozekowski, Joel; Pietz, Harlan L; Jegaskanda, Sinthujan; Dowdell, Kennichi; Vogel, Joshua S; Garabedian, Doreen; Oestreich, Makinna; Nguyen, Hanh; Ali, Mir A; Lumbard, Keith; Hunsberger, Sally; Reifert, Jack; Haynes, Winston A; Sawyer, Jaymie R; Shon, John C; Daugherty, Patrick S; Cohen, Jeffrey I
  3. The Journal of Infectious Diseases. 2021, Nov 16; 224(9): 1509-1519.
  1. 2.   A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus 2 Vaccine, HSV529, in Adults With or Without HSV Infection
  2. Dropulic, Lesia K; Oestreich, Makinna C; Pietz, Harlan L; Laing, Kerry J; Hunsberger, Sally; Lumbard,Keith; Garabedian,Doreen; Turk, Siu Ping; Chen, Aiying; Hornung, Ronald L; Seshadri, Chetan; Smith, Malisa T; Hosken, Nancy A; Phogat, Sanjay; Chang, Lee-Jah; Koelle, David M; Wang, Kening; Cohen, Jeffrey I
  3. The Journal of infectious diseases. 2019, SEP 15; 220(6): 990-1000.
  1. 3.   The history of N-methanocarbathymidine: The investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agent
  2. Marquez, V. E.; Hughes, S. H.; Sei, S.; Agbaria, R.
  3. Antiviral Research. 2006, Sep; 71(2-3): 268-275.
  1. 4.   Potent antiviral activity of North-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus
  2. Zhu, W. M.; Burnette, A.; Dorjsuren, D.; Roberts, P. E.; Huleihel, M.; Shoemaker, R. H.; Marquez, V. E.; Agbaria, R.; Sei, S.
  3. Antimicrobial Agents and Chemotherapy. 2005, DEC; 49(12): 4965-4973.
  1. 5.   Dynamics of the antiviral activity of N-methanocarbathymidine against herpes simplex virus type 1 in cell culture
  2. Huleihel, M.; Talishanisky, M.; Ford, H.; Marquez, V. E.; Kelley, J. A.; Johns, D. G.; Agbaria, R.
  3. International Journal of Antimicrobial Agents. 2005, MAY; 25(5): 427-432.
  1. 6.   TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling
  2. Kim, Y. S.; Nedospasov, S. A.; Liu, Z. G.
  3. Molecular and Cellular Biology. 2005, MAR; 25(6): 2130-2137.
  1. 7.   Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells
  2. Megjugorac, N. J.; Young, H. A.; Amrute, S. B.; Olshalsky, S. L.; Fitzgerald-Bocarsly, P.
  3. Journal of Leukocyte Biology. 2004 75(3): 504-514.
  1. 8.   Metabolic pathways of N-methanocarbathymidine, a novel antiviral agent, in native and herpes simplex virus type 1 infected Vero cells
  2. Zalah, L.; Huleihel, M.; Manor, E.; Konson, A.; Ford, H.; Marquez, V. E.; Johns, D. G.; Agbaria, R.
  3. Antiviral Research. 2002 55(1): 63-75.
  1. 9.   Biosynthetic ganciclovir triphosphate: Its isolation and characterization from ganciclovir-treated herpes simplex thymidine kinase-transduced murine cells
  2. Agbaria, R.; Candotti, F.; Kelley, J. A.; Hao, Z.; Johns, D. G.; Cooney, D. A.; Blaese, R. M.; Ford, H.
  3. Biochemical and Biophysical Research Communications. 2001 289(2): 525-530.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel